ArticleCancers2022

STIL Promotes Tumorigenesis of Bladder Cancer by Activating PI3K/AKT/mTOR Signaling Pathway and Targeting C-Myc.

Hua Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.